Antares Pharma, Inc. (ATRS)

Retained Earnings

-$178.66M

Quarterly · Period ending: · USD

ATRS logo

ATRS Retained Earnings

Latest reported-$176.34M
ATRS FY Retained Earnings (-$11.54M → -$176.34M)
High-resolution chart · PNG

ATRS retained earnings history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Retained Earnings — Annual fiscal periods (USD)
Period endingRetained Earnings (USD)
-176,337,000
-222,626,000
-278,827,000
-276,800,000
-270,285,000
-253,445,306
-229,106,502
-208,447,656
-173,295,941
-152,789,165
-141,361,715
-136,973,795
-130,882,597
-120,591,845
-107,901,392
-99,322,453
-91,123,107
-82,575,151
-74,126,619
-41,165,798
-29,457,033
-29,084,474
-24,147,835
-20,295,944
-14,512,234
-11,540,467
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.